Kraj: Wielka Brytania
Język: angielski
Źródło: MHRA (Medicines & Healthcare Products Regulatory Agency)
Aspirin
Mawdsley-Brooks & Company Ltd
B01AC06
Aspirin
75mg
Dispersible tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02090000
DISPERSIBLE ASPIRIN 75MG TABLETS _100 TABLETS_ Read attached leaflet for full instructions before use. INGREDIENTS: Each tablet contains: Aspirin 75mg. Also contains lactose and sodium. USAGE: an antiplatelet agent which helps to prevent blood clots in people who have had a stroke, heart attack or by-pass surgery. HOW TO TAKE: Check the bottle seal is not broken before first use. If it is do not take the tablets. The tablets should be dispersed in water before taking by mouth. DOSAGE: The advice of a doctor should be sought before commencing therapy for the first time. The usual dose, for long term use, is 1 or 2 tablets ➜ once daily. In some circumstances a higherdose may be appropriate, especially in the short term and up to 4 tablets a day may be used on the advice of a doctor. DO NOT GIVE TO CHILDREN AGED UNDER 16 YEARS, UNLESS ON THE ADVICE OF A DOCTOR. WARNINGS DO NOT EXCEED THE STATED DOSE. STORAGE: Do not store above 25°C. Store in the original package. KEEP OUT OF THE SIGHT AND REACH OF CHILDREN. USE BY THE DATE ON THE LABEL EDGE. MA HOLDER: Aspar Pharmaceuticals Ltd, London, NW9 0EQ PL 08977/0007 Patient Information Leaflet for DISPERSIBLE ASPIRIN TABLETS 75MG _Read this leaflet carefully before taking these tablets. It does not _ _contain all the information about your medicine that you may need _ _to know, so ask your doctor or pharmacist if you have any questions._ _This leaflet only applies to Dispersible Aspirin Tablets 75mg_ 1. WHAT THESE TABLETS DO These tablets contain Aspirin which is used to help prevent heart attacks and strokes in people who have previously suffered these conditions or who have under gone by-pass surgery. 2. CHECK BEFORE YOU TAKE Before starting long term use of Aspirin you must consult your doctor who will discuss the benefits and risks of this therapy with you Do not take these tablets if you: • Are allergic to Aspirin, NSAIDs which includes those when in attacks of asthma, angioedema, uticaria or rhinitis have been precipitated by aspirin or any other NSAID or any of Przeczytaj cały dokument
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Dispersible Aspirin Tablets BP 75mg Dispersible Aspirin 75mg Tablets POST MI® 75mg Dispersible Tablets Boots Aspirin 75mg Dispersible tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Aspirin BP 75.0mg 3. PHARMACEUTICAL FORM Dispersible tablets 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the secondary prevention of thrombotic cerebrovascular or cardiovascular disease and following by-pass surgery. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION The advice of a doctor should be sought before commencing therapy for the first time. The usual dosage, for long term use, is 75-150mg daily. In some circumstances, a higher dose may be appropriate, especially in the short term, and up to 300mg a day may be used on the advice of a doctor. _Children: _Do not give to children aged under 16 years, unless specifically indicated (e.g. for Kawasaki’s disease). 4.3 CONTRAINDICATIONS Aspirin is contraindicated in patients with; • active peptic ulceration or a history of peptic ulceration. • Haemophilia, haemorrhagic disease or a history of bleeding disorders. • Gout or a history of gout. • Hypersensitivity to aspirin (e.g. asthma, rhinitis, angioedema or urticaria), other NSAIDs or other tablet excipients • During the third trimester of pregnancy • children under 16 (except for the treatment of Still’s disease), • breast feeding,. • concurrent anticoagulant therapy. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Before commencing long term aspirin therapy, for the management of cardiovascular and cerebrovascular disease, patients should consult their doctor who can advise on the relative benefits versus the risks for the individual patient. Administer with caution in the presence of renal or hepatic impairment, dehydration. There is a possible association between aspirin and Reye’s syndrome when given to children. Reye’s syndrome is a very rare disease, which affects the brain and liver and can be fatal. For this reason aspirin should n Przeczytaj cały dokument